My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Baudax Bio, Inc. - Common stock (NQ:BXRX)

N/A UNCHANGED

Last Price Updated: 3:50 PM EST, Nov 15, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Baudax Bio, Inc. - Common stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

AstraZeneca-Ionis Partnered Rare Disease Drug Data Shows Sustained Benefit; Drug Under FDA Review ↗

March 27, 2023

Via Benzinga

Why Baudax Bio Shares Are Trading Higher Today ↗

March 27, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 16, 2023

Via Benzinga

Looking Into Baudax Bio's Return On Capital Employed ↗

February 28, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 17, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 25, 2023

Via Benzinga

Why Baudax Bio Shares Trading Higher Today ↗

January 24, 2023

Via Benzinga

Why Is Baudax Bio (BXRX) Stock Up 50% Today? ↗

January 24, 2023

BXRX stock is soaring today as Baudax Bio's novel medical product could result in time and cost savings for patients and hospitals.

Via InvestorPlace

Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 25, 2023

Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares surged 85% to $2.2200. Sonoma Pharmaceuticals and EMC Pharma announced Department of Defense DAPA registration for Microcyn(R) Rx products.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 25, 2023

Via Benzinga

Dow Rises 80 Points; Altamira Therapeutics Shares Plunge ↗

January 24, 2023

U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 80 points on Tuesday. The Dow traded up 0.24% to 33,710.06 while the NASDAQ fell 0.21% to 11,340.24. The S&P 500...

Via Benzinga

Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 24, 2023

Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 24, 2023

Via Benzinga

Stocks Static As Earnings Season Heats Up ↗

January 24, 2023

After a strong start to the week, stocks are struggling for direction today as investors unpack the latest batch of earnings reports.

Via Talk Markets

Dow Edges Higher; Crude Oil Down 1% ↗

January 24, 2023

U.S. stocks traded mostly flat midway through trading, with the Dow Jones trading slightly higher on Tuesday. The Dow traded up 0.03% to 33,638.42 while the NASDAQ fell 0.07% to 11,356.65. The S&P 500...

Via Benzinga

Dow Drops 100 Points; Verizon Issues Weak Earnings Forecast ↗

January 24, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.31% to 33,524.12 while the NASDAQ fell...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 24, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 03, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 30, 2022

Via Benzinga

Why Dermata Therapeutics Shares Are Trading Higher By Over 100%; Here Are 21 Stocks Moving Premarket ↗

December 30, 2022

Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares rose 105% to $0.41 in pre-market trading after the company requested to withdraw its registration on Form S-1 and said it does not intend to...

Via Benzinga

Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session ↗

December 29, 2022

Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 29, 2022

Via Benzinga

Dow Surges 250 Points; Jobless Claims Rise To 225,000 ↗

December 29, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining around 250 points on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 29, 2022

Via Benzinga

Why Cal-Maine Foods Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket ↗

December 29, 2022

Gainers Quotient Limited (NASDAQ: QTNT) shares rose 125% to $0.54 in pre-market trading after dropping around 38% on Wednesday. Quotient recently announced the intent to voluntary delist from the...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 28, 2022

Via Benzinga

The 7 Most Sold-Off Stocks of 2022 ↗

December 24, 2022

With 2022 rapidly coming to a close, it’s time to take a look back at the most sold-off stocks so you know which names to avoid.

Via InvestorPlace

Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session ↗

December 22, 2022

Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 22, 2022

Via Benzinga

Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session ↗

December 20, 2022

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.